查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541310

2024-2032 年 HPV 检测和 PAP 检测市场报告（按检测类型、产品、应用、最终用户和地区）

HPV Testing and PAP Test Market Report by Test Type, Product, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2023年，IMARC GroupHPV检测及PAP检测市场规模达42亿美元。

人类乳突病毒 (HPV) 是一种性传染感染 (STI)，可导致子宫颈癌、口咽癌、阴茎癌和外阴癌。它可以在各种测试和程序的支持下进行检测，例如 HPV 和巴氏 (PAP) 测试。这些评估包括标本的显微镜观察以及子宫颈癌、头颈癌筛检。其中，HPV 检测用于评估在尖锐湿疣形成之前是否存在人类乳突病毒，而 PAP 检测则用于确定细胞的变化以及子宫颈是否存在异常细胞。

HPV 检测与 PAP 检测市场趋势：

子宫颈癌的盛行率不断增加，尤其是在成年人口中。由于乳头瘤病毒的存在，促进了对新型、技术先进且具有成本效益的 HPV 和 PAP 筛检的需求，这是主要推动市场成长的主要因素之一。与此一致的是，引入机器辅助、血浆和游离脱氧核糖核酸 (DNA) 筛检来检测和监测早期 HPV 感染癌症的治疗反应，是另一个生长诱导因素。由于冠状病毒病 (COVID-19) 大流行的突然爆发，主要参与者不断进行临床试验、开发和产品发布，例如易于使用的家庭 HPV 筛检测试，进一步支持了这一点。优势。其他因素，例如医疗保健部门的快速扩张以及政府机构和非政府组织 (NGO) 为提高人们对子宫颈癌原因以及进行 HPV 和 PAP 检测的好处的认识而采取的众多有利倡议，为市场创造积极的前景。

本报告回答的关键问题

  • 全球HPV检测和PAP检测市场有多大？ 2024-2032年全球HPV检测和PAP检测市场的预期成长率是多少？
  • 推动全球 HPV 检测和 PAP 检测市场的关键因素是什么？
  • COVID-19 对全球 HPV 检测和 PAP 检测市场有何影响？
  • 根据检测类型，全球 HPV 检测和 PAP 检测市场的细分如何？
  • 基于产品的全球 HPV 检测和 PAP 检测市场的细分如何？
  • 基于应用的全球 HPV 检测和 PAP 检测市场的细分如何？
  • 基于最终用户的全球 HPV 检测和 PAP 检测市场的细分如何？
  • 全球HPV检测和PAP检测市场的重点区域有哪些？
  • 全球 HPV 检测和 PAP 检测市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球 HPV 检测与 PAP 检测市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按测试类型

  • HPV检测
    • 市场趋势
    • 市场预测
  • 巴氏涂片检查
    • 市场趋势
    • 市场预测
  • 联合测试
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依产品

  • 仪器仪表
    • 市场趋势
    • 市场预测
  • 耗材
    • 市场趋势
    • 市场预测
  • 服务
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按应用

  • 子宫颈癌筛检
    • 市场趋势
    • 市场预测
  • 阴道癌筛检
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院和诊所
    • 市场趋势
    • 市场预测
  • 实验室
    • 市场趋势
    • 市场预测
  • 诊断中心
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Arbor Vita Corporation
    • AstraZeneca plc
    • Becton Dickinson and Company
    • Biocon Limited
    • bioMerieux SA
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Hologic Inc.
    • NURX Inc. (Thirty Madison Inc.)
    • Qiagen NV
    • Quest Diagnostics Incorporated
    • Seegene Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A5889

The global HPV testing and PAP test market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.

Human papillomavirus (HPV) is a sexually transmitted infection (STI) that causes cancer of the cervix, oropharynx, penis, and vulva. It can be detected with the support of various tests and procedures, such as HPV and Papanicolaou (PAP) test. These assessments comprise microscopic observation of specimens and cervical, head and neck cancer screening. Amongst these, HPV tests are deployed for assessing the presence of human papillomavirus that precede the development of genital warts, whereas PAP tests are used for determining changes in the cell and the presence of abnormal cells in cervices.

HPV Testing and PAP Test Market Trends:

The increasing prevalence of cervical cancer, especially amongst the adult demographics. due to presence of papillomavirus is facilitating the need for novel, technologically advanced, and cost-effective HPV and PAP screening, which is one of the major factors primarily driving the market growth. In line with this, the introduction of machine-assisted, plasma- and cell-free deoxyribonucleic acid (DNA) screenings to detect and monitor the treatment response of HPV-infected cancers at the early phase is acting as another growth-inducing factor. This is further supported by the continuous clinical trials, developments, and product launches by key players, such as the easy-to-use home HPV screening test, on account of the sudden outbreak of coronavirus disease (COVID-19) pandemic, is providing them with a competitive edge in the market. Other factors, such as the rapid expansion in the healthcare sector and the numerous favorable initiatives undertaken by the government bodies and the non-governmental organizations (NGOs) for sensitizing people regarding the causes of cervical cancer and the benefits of having HPV and PAP tests are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global HPV testing and PAP test market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on test type, product, application and end user.

Breakup by Test Type:

HPV Test

Pap Test

Co-testing

Breakup by Product:

Instruments

Consumables

Services

Breakup by Application:

Cervical Cancer Screening

Vaginal Cancer Screening

Breakup by End User:

Hospitals and Clinics

Laboratories

Diagnostic Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, AstraZeneca plc, Becton Dickinson and Company, Biocon Limited, bioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., NURX Inc. (Thirty Madison Inc.), Qiagen N.V., Quest Diagnostics Incorporated, Seegene Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. How big is the global HPV testing and PAP test market?
  • 2. What is the expected growth rate of the global HPV testing and PAP test market during 2024-2032?
  • 3. What are the key factors driving the global HPV testing and PAP test market?
  • 4. What has been the impact of COVID-19 on the global HPV testing and PAP test market?
  • 5. What is the breakup of the global HPV testing and PAP test market based on the test type?
  • 6. What is the breakup of the global HPV testing and PAP test market based on the product?
  • 7. What is the breakup of the global HPV testing and PAP test market based on the application?
  • 8. What is the breakup of the global HPV testing and PAP test market based on the end user?
  • 9. What are the key regions in the global HPV testing and PAP test market?
  • 10. Who are the key players/companies in the global HPV testing and PAP test market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global HPV Testing and PAP Test Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 HPV Test
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Pap Test
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Co-testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Consumables
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Services
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Cervical Cancer Screening
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Vaginal Cancer Screening
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diagnostic Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Arbor Vita Corporation
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 AstraZeneca plc
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Becton Dickinson and Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Biocon Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 bioMerieux SA
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Danaher Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 F. Hoffmann-La Roche AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Hologic Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 NURX Inc. (Thirty Madison Inc.)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Qiagen N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Quest Diagnostics Incorporated
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
    • 15.3.13 Seegene Inc.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
    • 15.3.14 Thermo Fisher Scientific Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: HPV Testing and PAP Test Market: Major Drivers and Challenges
  • Figure 2: Global: HPV Testing and PAP Test Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: HPV Testing and PAP Test Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: HPV Testing and PAP Test Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: HPV Testing and PAP Test Market: Breakup by Product (in %), 2023
  • Figure 6: Global: HPV Testing and PAP Test Market: Breakup by Application (in %), 2023
  • Figure 7: Global: HPV Testing and PAP Test Market: Breakup by End User (in %), 2023
  • Figure 8: Global: HPV Testing and PAP Test Market: Breakup by Region (in %), 2023
  • Figure 9: Global: HPV Testing and PAP Test (HPV Test) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: HPV Testing and PAP Test (HPV Test) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: HPV Testing and PAP Test (Pap Test) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: HPV Testing and PAP Test (Pap Test) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: HPV Testing and PAP Test (Co-testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: HPV Testing and PAP Test (Co-testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: HPV Testing and PAP Test (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: HPV Testing and PAP Test (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: HPV Testing and PAP Test (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: HPV Testing and PAP Test (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: HPV Testing and PAP Test (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: HPV Testing and PAP Test (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: HPV Testing and PAP Test (Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: HPV Testing and PAP Test (Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: HPV Testing and PAP Test (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: HPV Testing and PAP Test (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: HPV Testing and PAP Test (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: HPV Testing and PAP Test (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: North America: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: North America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: United States: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: United States: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Canada: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Canada: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Asia-Pacific: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Asia-Pacific: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: China: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: China: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Japan: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Japan: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: India: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: India: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: South Korea: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: South Korea: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Australia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Australia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Indonesia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Indonesia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Europe: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Europe: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Germany: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Germany: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: France: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: France: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: United Kingdom: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: United Kingdom: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Italy: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Italy: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Spain: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Spain: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Russia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Russia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Latin America: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Latin America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Brazil: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Brazil: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Mexico: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Mexico: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Middle East and Africa: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Middle East and Africa: HPV Testing and PAP Test Market: Breakup by Country (in %), 2023
  • Figure 81: Middle East and Africa: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Global: HPV Testing and PAP Test Industry: SWOT Analysis
  • Figure 83: Global: HPV Testing and PAP Test Industry: Value Chain Analysis
  • Figure 84: Global: HPV Testing and PAP Test Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: HPV Testing and PAP Test Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: HPV Testing and PAP Test Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 3: Global: HPV Testing and PAP Test Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: HPV Testing and PAP Test Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: HPV Testing and PAP Test Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: HPV Testing and PAP Test Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: HPV Testing and PAP Test Market: Competitive Structure
  • Table 8: Global: HPV Testing and PAP Test Market: Key Players